Latest News

Norgine to acquire Merus

Norgine HQ in Amsterdam, The Netherlands, © Norgine


by tg

Dutch Norgine BV will take-over Merus Labs International Inc. Under the agreement, Norgine will acquire all outstanding shares for US$1.65 per share in cash.

The transaction of US$342m will be financed through a combination of available cash and new credit facilities that Norgine has secured prior to the agreement. The transaction price of US$1.65 per share represents a premium of 63.4% to the closing price of US$1.01 on the TSX on May 10, 2017 and a premium of 55.1% over the 30-day volume weighted average price of $1.06 on the TSX.  

In 2016, Norgine’s total sales revenue was €295 million. The company is specialised in gastroenterology, hepatology, cancer and supportive  

Rothschild & Co. was acting as financial advisor and Torys LLP was acting as legal counsel to Merus. RBC Capital Markets is acting as financial advisor and Stikeman Elliott LLP is acting as legal counsel to Norgine.   

Global bioeconomy in the spotlight

Whereas first editions of the summit took place in Berlin in 2015 and 2018, the third edition was organized as a digital conference week from 16th to...

Novo Holdings creates Hemab

Hemab ApS will combine antibody know-how from Genmab A/S and Novo Nordisk to fight medically underserved orphan bleeding disorders.  The company...

COVID-19 jab: EU signs contract with JNJ

Both parties didn't announce a price for the jab. However, according to JNJ’s deal with the US government, which ordered 100 million doses, the...

Cell and gene therapy specialist Minaris expanding

In Europe, the Showa Denko Materials Co., Ltd. subsidiary will invest US$40.7 million to build a new state-of-the-art facility in proximity to an...

European Circular Bioeconomy Fund growing

Nurition world market leader Nestlé as well as Neste Oyj, Volkswohl Bund Versicherungen, NRW.BANK and an undisclosed family office contributed to the...

Protein Brewery raise €22m in Series A

The Series A investment round, which brings the total amount invested into the Dutch food and feed maker to €26m, was led by Novo Holdings. New...

Pfizer/BioNTech sign vaccine contract with EC

The deal includes an option for the European Commission to request an additional 100 million doses of BNT-162-b2. That's the largest initial order of...